233 related articles for article (PubMed ID: 27703006)
1. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation.
Mitra S; Ghosh B; Gayen N; Roy J; Mandal AK
J Biol Chem; 2016 Nov; 291(47):24579-24593. PubMed ID: 27703006
[TBL] [Abstract][Full Text] [Related]
2. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P
Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678
[TBL] [Abstract][Full Text] [Related]
3. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.
Grammatikakis N; Lin JH; Grammatikakis A; Tsichlis PN; Cochran BH
Mol Cell Biol; 1999 Mar; 19(3):1661-72. PubMed ID: 10022854
[TBL] [Abstract][Full Text] [Related]
4. Analyses of the oncogenic BRAF
Cope NJ; Novak B; Liu Z; Cavallo M; Gunderwala AY; Connolly M; Wang Z
J Biol Chem; 2020 Feb; 295(8):2407-2420. PubMed ID: 31929109
[TBL] [Abstract][Full Text] [Related]
5. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.
Wang P; Laster K; Jia X; Dong Z; Liu K
Mol Cancer; 2023 Dec; 22(1):208. PubMed ID: 38111008
[TBL] [Abstract][Full Text] [Related]
6. HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation.
Oberoi J; Guiu XA; Outwin EA; Schellenberger P; Roumeliotis TI; Choudhary JS; Pearl LH
Nat Commun; 2022 Nov; 13(1):7343. PubMed ID: 36446791
[TBL] [Abstract][Full Text] [Related]
7. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.
Zhang BH; Guan KL
EMBO J; 2000 Oct; 19(20):5429-39. PubMed ID: 11032810
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 provides a platform for kinase dephosphorylation by PP5.
Jaime-Garza M; Nowotny CA; Coutandin D; Wang F; Tabios M; Agard DA
Nat Commun; 2023 Apr; 14(1):2197. PubMed ID: 37069154
[TBL] [Abstract][Full Text] [Related]
9. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase.
Stancato LF; Silverstein AM; Owens-Grillo JK; Chow YH; Jove R; Pratt WB
J Biol Chem; 1997 Feb; 272(7):4013-20. PubMed ID: 9020108
[TBL] [Abstract][Full Text] [Related]
10. ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.
Rebocho AP; Marais R
Oncogene; 2013 Jun; 32(26):3207-12. PubMed ID: 22926515
[TBL] [Abstract][Full Text] [Related]
11. The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho-Ser-621 in the C terminus of CRAF.
Yuan J; Ng WH; Yap J; Chia B; Huang X; Wang M; Hu J
J Biol Chem; 2018 Sep; 293(37):14276-14284. PubMed ID: 30030377
[TBL] [Abstract][Full Text] [Related]
12. Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors.
Chatelle CV; Hövermann D; Müller A; Wagner HJ; Weber W; Radziwill G
Sci Rep; 2016 Mar; 6():23713. PubMed ID: 27025703
[TBL] [Abstract][Full Text] [Related]
13. The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation.
Grammatikakis N; Vultur A; Ramana CV; Siganou A; Schweinfest CW; Watson DK; Raptis L
J Biol Chem; 2002 Mar; 277(10):8312-20. PubMed ID: 11751906
[TBL] [Abstract][Full Text] [Related]
14. Thr90 phosphorylation of Hsp90α by protein kinase A regulates its chaperone machinery.
Wang X; Lu XA; Song X; Zhuo W; Jia L; Jiang Y; Luo Y
Biochem J; 2012 Jan; 441(1):387-97. PubMed ID: 21919888
[TBL] [Abstract][Full Text] [Related]
15. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells.
Dunn DM; Woodford MR; Truman AW; Jensen SM; Schulman J; Caza T; Remillard TC; Loiselle D; Wolfgeher D; Blagg BS; Franco L; Haystead TA; Daturpalli S; Mayer MP; Trepel JB; Morgan RM; Prodromou C; Kron SJ; Panaretou B; Stetler-Stevenson WG; Landas SK; Neckers L; Bratslavsky G; Bourboulia D; Mollapour M
Cell Rep; 2015 Aug; 12(6):1006-18. PubMed ID: 26235616
[TBL] [Abstract][Full Text] [Related]
16. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.
Vaughan CK; Mollapour M; Smith JR; Truman A; Hu B; Good VM; Panaretou B; Neckers L; Clarke PA; Workman P; Piper PW; Prodromou C; Pearl LH
Mol Cell; 2008 Sep; 31(6):886-95. PubMed ID: 18922470
[TBL] [Abstract][Full Text] [Related]
17. Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration.
Mooz J; Oberoi-Khanuja TK; Harms GS; Wang W; Jaiswal BS; Seshagiri S; Tikkanen R; Rajalingam K
Sci Signal; 2014 Aug; 7(337):ra73. PubMed ID: 25097033
[TBL] [Abstract][Full Text] [Related]
18. Extracellular ATP stimulates an inhibitory pathway towards growth factor-induced cRaf-1 and MEKK activation in astrocyte cultures.
Lenz G; Gonçalves D; Luo Z; Avruch J; Rodnight R; Neary JT
J Neurochem; 2001 May; 77(4):1001-9. PubMed ID: 11359865
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
Kiel C; Serrano L
Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of mutations in Ha-Ras that selectively decrease binding to cRaf-1.
Winkler DG; Johnson JC; Cooper JA; Vojtek AB
J Biol Chem; 1997 Sep; 272(39):24402-9. PubMed ID: 9305899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
